Daniel Talmasov, MD
On the web
Overview
Daniel Talmasov, MD, is a board-certified neurologist and psychiatrist in the Division of Aging and Dementia at Columbia University Irving Medical Center. After earning his M.D. at Stony Brook University, Dr. Talmasov completed his residency in psychiatry at Brigham and Women's Hospital / Harvard Medical School, followed by residency in neurology at NYU Langone / Bellevue Hospital Center, where he also served as chief resident. Dr. Talmasov then completed advanced training in Behavioral Neurology & Neuropsychiatry at Columbia University Irving Medical Center.
Dr. Talmasov specializes in the treatment of patients with behavioral, cognitive, and emotional symptoms of neurodegenerative disease, including Frontotemporal Dementia and related disorders. He also provides neurobehavioral consultation for patients in the Eleanor and Lou Gehrig ALS Center and the Huntington's Disease Society Center of Excellence at Columbia.
Areas of Expertise / Conditions Treated
- Alzheimer's Disease
- Dementia
- Frontotemporal Dementia
- Huntington's Disease (HD)
- Lewy Body Disease
- Memory Disorders
- Motor Neuron Disease
Academic Appointments
- Instructor in Neurology at CUMC
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Gender
- Male
Schedule an Appointment
Virtual Visits/Telehealth
Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
- Aetna Signature Administrators
- EPO
- HMO
- Medicare Managed Care
- NY Signature
- POS
- PPO
- Student Health
Affinity Health Plan
- Essential Plan
- Medicaid Managed Care
Amida Care
- Special Needs
Cigna
- EPO
- Great West (National)
- HMO
- Medicare Managed Care
- POS
- PPO
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicaid Managed Care
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross/Blue Shield
- EPO
- HMO
- Medicare Managed Care
- PPO
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
Fidelis Care
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Medicare Managed Care
Local 1199
- Local 1199
MagnaCare (National)
- MagnaCare
Medicare
- Railroad
- Traditional Medicare
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
RiverSpring
- Special Needs
UnitedHealthcare
- Compass (Exchange)
- Empire Plan
- HMO
- Medicaid (Community Plan)
- Medicare Managed Care
- Oxford Freedom
- Oxford HMO
- Oxford Liberty
- POS
- PPO
VNSNY CHOICE
- Medicare Managed Care
- SelectHealth
- Special Needs
WellCare
- Medicaid Managed Care
- Medicare Managed Care
World Trade Center Health Plan
- World Trade Center Health Plan
Credentials & Experience
Education & Training
- MD, 2015 Stony Brook University
- Residency: 2019 Psychiatry, Brigham and Women’s Hospital / Harvard Medical School
- Residency: 2022 Neurology, NYU Grossman School of Medicine
- Fellowship: 2025 Behavioral Neurology, Columbia University Irving Medical Center
Board Certifications
- Neurology
- Psychiatry
Honors & Awards
- 2025 - Alzheimer’s Association Clinician Scientist Fellowship, Alzheimer’s Association
- 2024 - Sidney R. Baer Jr. Career Development Award, American Neuropsychiatric Association
- 2018 - Stanley Cobb Award, Boston Society for Neurology, Neurosurgery, and Psychiatry
- 2018 - Harry C. Solomon Award, Harvard Medical School, Department of Psychiatry
- 2018 - DuPont-Warren Fellowship, Harvard Medical School, Department of Psychiatry
Research
Dr. Talmasov's research focuses on brain pathology that alters human behavior. In past work using lesion network mapping, he studied the disruption of behaviorally critical brain circuits in patients with mania and hallucinations following focal brain lesions. His current research program combines computational genomics and neuropathology to investigate why specific frontal cortical neurons are vulnerable to degeneration in frontotemporal dementia (FTD), both in C9orf72 mutation carriers and in sporadic FTD.
For a complete list of publications, please visit PubMed.gov